WinstonWınston
Back
P3 Health Partners logo

P3 Health Partners

PIII
24
Medical - Care Facilities · Healthcare
Price
$10.31
-0.03 (-0.24%)
Market Cap
$33.8M
Exchange
NASDAQ
Winston Score
24
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Mixed
Valuation
Data not available

Share count rising — dilution

+293.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 832K (2021) → 3.3M (2025)

Winston Score History

The full picture

P3 Health Partners is a physician-led healthcare company that manages primary care for older adults, mostly people on Medicare. It works with doctors and health systems to coordinate all of a patient's medical needs — from regular checkups to specialist visits — under one organized system. The company operates in a few U.S. states and focuses on a care model designed to keep patients healthier and out of the hospital.

P3 makes money through value-based care contracts, mainly with Medicare Advantage health plans. Instead of charging per visit, it receives a fixed payment per patient and tries to keep costs below that amount — so managing patient health efficiently is how it earns a profit. The company is small, currently unprofitable, and carries a deeply negative return on invested capital, which signals it is spending significantly more than it earns. The main risk is whether it can scale its patient base fast enough to reach profitability before running out of financial runway.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+191.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

44.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~1 months

$21M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

P3 Health Partners has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.0%
Thin — 0.0% gross margin
Profit after running costs
Operating Margin
10.7%
Modest — 10.7% operating margin
Return on the money invested
ROCE
-141.0%
Weak — -141.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+2.8%
Nearly flat sales (+2.8% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-8.7%
Burning cash (-8.7%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.44
Conservative — low debt load (0.44)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial